Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath Publishes Summer 2026 Issue of Alumni Journal

Read More

News & Insights

ASG’s Senior Secured Credit Facilities

August 30, 2017

Cravath represented Credit Suisse in connection with the arrangement of $325 million of senior secured credit facilities made available to ASG Technologies Group, Inc. (“ASG”), a leading provider of technology solutions. The facilities refinanced existing indebtedness of ASG, and will be used for working capital, capital expenditures and other general corporate purposes. The transaction closed on July 31, 2017.

The Cravath team included partner Michael S. Goldman, senior attorney Sarah F. Rosen and associates Paul L. Sandler and William A. Magioncalda on banking matters; and partner J. Leonard Teti II and associate Dmitry Zelik on tax matters. Valerie E. Wood also worked on banking matters.

Related Practices & Industries

  • Corporate
  • Banking and Credit
  • Tax
  • Technology

People

Name
Sarah F. Rosen
Title
Corporate
Title
Partner
Email
srosen@cravath.com
Phone
+1-212-474-1750
vCard
Download vCard

    Education

    • J.D., 2005, Columbia Law School
      Harlan Fiske Stone Scholar
    • B.A., 2002, New York University
      magna cum laude

    Admitted In

    • New York
    Photo
    Name
    J. Leonard Teti II
    Title
    Tax
    Title
    Partner
    Email
    lteti@cravath.com
    Phone
    +1-212-474-1896
    vCard
    Download vCard

      Education

      • J.D., 2005, University of Virginia School of Law
        Order of the Coif
      • A.B., 1999, Princeton University
        with Honors

      Admitted In

      • New York
      Photo
      Name
      Michael S. Goldman
      Title
      Corporate
      Title
      Retired Partner
      Email
      mgoldman@cravath.com
      Phone
      +1-212-474-1999
      vCard
      Download vCard

        Education

        • J.D., 1987, Fordham University School of Law
          cum laude
        • B.A., 1984, University of Pennsylvania
          cum laude

        Related News & Insights

        Deals & Cases

        July 06, 2026

        UVEX’s Upsize and Repricing of its Term Loan Facility

        Cravath represented the agent, mandated lead arrangers, and lenders in connection with the repricing of UVEX GROUP GmbH’s €400 million term loan facility and €50 million term loan add-on. UVEX GROUP GmbH is a portfolio company of Warburg Pincus. The transaction closed on June 19, 2026. 

        Deals & Cases

        April 06, 2026

        Versigent’s $1.35 Billion Credit Facilities and $1.6 Billion High‑Yield Senior Notes Offering in Connection with Aptiv PLC’s Spin‑Off of Versigent

        Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $1.35 billion of credit facilities made available to subsidiaries of Versigent Limited, a global leader in the design, development and manufacture of low voltage and high voltage electrical architectures and the holding company for Aptiv PLC’s Electrical Distribution Systems segment, which Aptiv PLC spun off into a separate, independent, publicly traded company. The proceeds were used to partially finance the spin‑off. The credit facilities consisted of a $500 million term loan facility and an $850 million revolving credit facility. The transaction closed on November 26, 2025.

        Deals & Cases

        February 20, 2026

        First Solar’s $1.5 Billion Revolving Credit Facility

        Cravath represented First Solar, Inc. in connection with its $1.5 billion revolving credit facility. First Solar is America’s leading photovoltaic solar technology and manufacturing company, and the only US‑headquartered company among the world’s largest solar manufacturers. The transaction closed on February 13, 2026.

        Deals & Cases

        January 08, 2026

        Genmab’s $3.5 Billion of Credit Facilities and Offering of $1.5 Billion Senior Secured Notes and $1 Billion Senior Unsecured Notes in Connection with its Acquisition of Merus

        Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $3.5 billion of credit facilities made available to Genmab, a leading international biotechnology company, and one of its wholly‑owned subsidiaries, Genmab Finance LLC, as part of the financing transactions undertaken in connection with its acquisition of Merus N.V., a leading oncology company developing innovative antibody therapeutics. The credit facilities consisted of a $2 billion term loan “B” facility, a $1 billion term loan “A” facility and a $500 million revolving credit facility. The transaction closed on December 12, 2025.

        Cravath Bicentennial

        Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

        Explore

        Cravath, Swaine & Moore LLP Logo
        • CONTACT US
        • OUR STORY
        • ALUMNI PORTAL
        • DISCLAIMERS & NOTICES

        Attorney Advertising. ©2026 Cravath, Swaine & Moore LLP.